Targeting ocular tissues with intravenously administered aptamers selected by in vivo SELEX
Ocular diseases create a significant economic burden and decrease in quality of life worldwide. Drugs and carrier molecules that penetrate ocular tissues after intravenous administration are needed for more efficient and patient-friendly treatment of ocular diseases. Here, ocular barrier-penetrating...
Saved in:
Main Authors: | Sonja Korhonen (Author), Katja Stenberg (Author), Umair Seemab (Author), Piia Bartos (Author), Katariina Mäkiniemi (Author), Jørgen Kjems (Author), Daniel Miotto Dupont (Author), Astrid Subrizi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vivo SELEX for Identification of Brain-penetrating Aptamers
by: Congsheng Cheng, et al.
Published: (2013) -
Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?
by: Mayte Sola, et al.
Published: (2020) -
Rapidly Neutralizable and Highly Anticoagulant Thrombin-Binding DNA Aptamer Discovered by MACE SELEX
by: Koji Wakui, et al.
Published: (2019) -
In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library
by: Hanlu Wang, et al.
Published: (2018) -
New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization
by: Abdullah Ozer, et al.
Published: (2014)